InvestorsHub Logo
Followers 10
Posts 1060
Boards Moderated 2
Alias Born 09/04/2000

Re: DanWebzster post# 70

Tuesday, 03/20/2018 2:49:08 PM

Tuesday, March 20, 2018 2:49:08 PM

Post# of 438
GILD is growing HIV business, but not nearly at the rate that its HCV business is declining

Cash = 36.7Bn on 12/31/17

Debt is ~33Bn

repatriating 5.5Bn in 2018 to reduce debt

will pay 0.57/share divy in 2018

spent 12.57Bn to acquire Kite and Cell Design Labs in 2017

Avoid, too many parts moving in different directions.

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.